Jeroen J de Vries, Maria João da Costa Caiado, Wilfred F A den Dunnen
{"title":"Postmortem cerebellar and brainstem alterations in episodic ataxia type 1 and 2: Expanding the clinicopathological spectrum.","authors":"Jeroen J de Vries, Maria João da Costa Caiado, Wilfred F A den Dunnen","doi":"10.5414/NP301727","DOIUrl":"10.5414/NP301727","url":null,"abstract":"<p><strong>Background: </strong>Episodic ataxias (EAs) are rare autosomal-dominant channelopathies presenting with recurrent attacks of ataxia and variable neurological features. While MRI studies suggest mild cerebellar atrophy in some patients, detailed neuropathological descriptions are lacking.</p><p><strong>Materials and methods: </strong>We examined postmortem brains and spinal cords from two genetically confirmed patients: EA1 (KCNA1 Val174Phe mutation) and EA2 (CACNA1A A253Y mutation). Routine histology and immunohistochemistry were performed.</p><p><strong>Results: </strong>In EA1, the cerebellar vermis and hemispheres showed narrowing of the folia, segmental Purkinje cell loss, Bergmann gliosis, and scattered torpedoes. The dentate nucleus contained focal lipofuscin-laden macrophages and Rosenthal fibers. Concurrently, α-synuclein pathology (Braak stage 3) was also present, along with sparse age-related tau tangles and minimal vascular amyloid. In EA2, only focal Purkinje cell loss was detected, but novel p62-positive axonal and dendritic inclusions were observed in the cerebellar cortex and inferior olive. No additional α-synuclein, tau, or amyloid pathology was found. A concurrent glioblastoma was identified as the immediate cause of death.</p><p><strong>Conclusion: </strong>These are the first detailed autopsy reports of EA1 and EA2. Both revealed cerebellar pathology, with EA1 showing more pronounced Purkinje cell degeneration, while EA2 demonstrated previously undescribed p62-positive inclusions. These findings expand the clinicopathological spectrum of EAs and highlight the value of postmortem studies in elucidating underlying disease mechanisms.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2026-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148254587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jeroen J de Vries, Maria João da Costa Caiado, Wilfred F A den Dunnen
{"title":"From genes to neuropathology: Integrative perspectives on the spectrum of spinocerebellar ataxias.","authors":"Jeroen J de Vries, Maria João da Costa Caiado, Wilfred F A den Dunnen","doi":"10.5414/NP301726","DOIUrl":"10.5414/NP301726","url":null,"abstract":"<p><p>This review describes the clinically and genetically heterogenous group of 52 Spinocerebellar ataxias (SCAs). After a brief description of the epidemiology and clinical spectrum, this review highlights the functional neuroanatomy, the need for sufficient sampling based on this knowledge, and showcases examples of neuropathology. In addition, a comprehensive overview of the pathogenesis of the different forms of spinocerebellar ataxias (SCAs) is given.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":"86-97"},"PeriodicalIF":0.7,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148254612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neuronal and glial intranuclear inclusions in a patient with oculopharyngodistal myopathy associated with noncoding GGC repeat expansions in <i>GIPC1</i>.","authors":"Kaoru Yagita, Hotake Takizawa, Terunori Sano, Yuji Nakayma, Masashi Ogasawara, Ichizo Nishino, Yasushi Ohya, Yuji Takahashi, Masaki Takao","doi":"10.5414/NP301744","DOIUrl":"10.5414/NP301744","url":null,"abstract":"<p><p>Noncoding GGC repeat expansion of various genes leads to oculopharyngodistal myopathy (OPDM), an adult-onset progressive neuromuscular disorder characterized by ophthalmoplegia, pharyngeal dysfunction, and distal limb muscular weakness. Recently, clinical overlap among noncoding GGC repeat-associated neuromuscular diseases, including OPDM, fragile X-associated tremor/ataxia syndrome (FXTAS), and neuronal intranuclear inclusion disease (NIID), has been recognized. Here, we present an autopsy case of OPDM with <i>GIPC1</i> mutation (OPDM2) in a 56-year-old man. Histopathological studies revealed loss of myelinated fibers in the cerebrum and the presence of neuronal and glial intranuclear inclusions, which are commonly observed in FXTAS and NIID. Numerous intranuclear inclusions in oligodendrocytes were a characteristic feature of our autopsied case. Although GGC repeat expansions in distinct genes produce similar neuropathological findings, such as neuronal and glial intranuclear inclusions, the affected cell populations differ.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":"107-114"},"PeriodicalIF":0.7,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147789854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jennifer Garry, Sophie Sabherwal, Seamus Looby, Francesca Brett
{"title":"Progressive multifocal leukoencephalopathy as the first presentation of an underlying lymphoproliferative disorder.","authors":"Jennifer Garry, Sophie Sabherwal, Seamus Looby, Francesca Brett","doi":"10.5414/NP301745","DOIUrl":"10.5414/NP301745","url":null,"abstract":"<p><p>Progressive multifocal leukoencephalopathy (PML) is a demyelinating central nervous system disease caused by John Cunningham virus (JCV) reactivation in immunosuppressed patients. Although classically associated with advanced HIV infection, PML also occurs in patients with hematological malignancies, organ transplants, or on immunomodulatory therapies. The mortality rate can be high, ranging from 20 to 90%, depending on the underlying condition. Clinical presentation is variable, depending on the site of brain involvement, and diagnosis requires integration of clinical, radiological, pathological, and virological findings [1, 2, 3, 4]. We present the case of a 69-year-old HIV-negative woman with progressive neurological decline, whose initial workup focused on a suspected lymphoproliferative disorder. This case demonstrates the classical neuroimaging and neuropathological features of PML.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":"115-121"},"PeriodicalIF":0.7,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148152010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julia Schuler, Sandra Baur, Federico Fusco, Felix Schicktanz, Benedikt Wiestler, Julian Canisius, Christian Mawrin, Denise Bernhardt, Arthur Wagner, Bernhard Meyer, Carolin Mogler, Claire Delbridge
{"title":"Rapid polymer-based immunohistochemistry for intraoperative CNS tumor diagnosis: A validation study.","authors":"Julia Schuler, Sandra Baur, Federico Fusco, Felix Schicktanz, Benedikt Wiestler, Julian Canisius, Christian Mawrin, Denise Bernhardt, Arthur Wagner, Bernhard Meyer, Carolin Mogler, Claire Delbridge","doi":"10.5414/NP301731","DOIUrl":"10.5414/NP301731","url":null,"abstract":"<p><p>Intraoperative diagnostics in neuro-oncology face a critical gap between the morphological limitations of hematoxylin-eosin staining or toluidine blue staining and the time-intensive nature of conventional immunohistochemistry (IHC). This delay hinders real-time surgical decision-making, particularly in distinguishing gliomas, metastases, and lymphomas. To address this, we validated a novel, rapid IHC protocol utilizing directly conjugated polymerized horseradish peroxidase (pHRP) antibodies, designed to deliver results in under 30 minutes. We evaluated the performance of pan-cytokeratin (pan-CK), glial fibrillary acidic protein (GFAP), and cluster of differentiation 20 (CD20) antibodies on 115 intraoperative frozen tissue samples. Staining quality was assessed using a 4-tiered scoring system (from 0 to 3+). The cytoplasmic markers GFAP and pan-CK demonstrated excellent robustness and reliability, achieving mean scores of 2.6 and 2.47, respectively, with over 68% of cases showing strong, specific staining (3+). The membrane-bound marker CD20 showed more variability (mean score 2.07), highlighting the influence of antigen localization on this rapid protocol. Our findings demonstrate that this rapid IHC method is a viable and highly effective tool for the intraoperative differentiation of central nervous system tumors, particularly for cytoplasmic antigens. By providing crucial morphological information in near real-time, this approach has the potential to significantly enhance diagnostic precision during surgery, enabling immediate, tailored therapeutic strategies and improving patient outcomes.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":"98-106"},"PeriodicalIF":0.7,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147870249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maysa Al-Hussaini, Sarah Al Sharie, Saif Azzam, Madiha Erashdi, Asem Mansour, Mouness Obeidat
{"title":"Bifocal cerebellar liponeurocytoma with atypical features: A case report and a literature review.","authors":"Maysa Al-Hussaini, Sarah Al Sharie, Saif Azzam, Madiha Erashdi, Asem Mansour, Mouness Obeidat","doi":"10.5414/NP301728","DOIUrl":"10.5414/NP301728","url":null,"abstract":"<p><p>Cerebellar liponeurocytoma (cLNC) is a rare tumor. It affects adults with no sex predilection. It appears as a heterogeneously enhancing mass, most commonly unifocal. Histologically, it is a biphasic neurocytic tumor with lipomatous component, with minimal atypia, and low proliferative index, corresponding to central nervous system (CNS) World Health Organization (WHO) grade 2. <i>TP53</i> missense mutation is reported in 20% of cases. Gross total resection, with or without radiotherapy, is considered an adequate treatment. Bifocality and features of anaplasia are rarely reported. We are reporting a 41-year-old lady with bilateral cerebellar contrast-enhancing masses who underwent gross total resection 3 months apart. Pathology revealed features consistent with cLNC. However, the tumor resected from the right cerebellar hemisphere demonstrated atypical morphological features, including microvascular proliferation and necrosis. Ki-67 proliferative marker was estimated at 10% in the most active areas. Next-generation sequencing (NGS) revealed 2 pathogenic mutations within exonic regions of <i>ERBB2</i>, and <i>PIK3CA</i> genes, and a variant mutation of unknown significance (VUS) involving the <i>PDGFRA</i> gene. DNA methylation profiling confirmed the diagnosis of cLNC. The patient has been under observation without any further intervention for 70 months since diagnosis, with no evidence of disease recurrence. In addition to the rarity of cLNC, this is a unique case in terms of bifocality, anaplastic histology, and the described genetic abnormalities.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":"56-65"},"PeriodicalIF":0.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147700860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Masayuki Shintaku, Tetsuo Hashiba, Masahiro Nonaka, Akio Asai, Koji Tsuta
{"title":"The \"Azzopardi phenomenon\" in high-grade astrocytoma with a PNET-like component.","authors":"Masayuki Shintaku, Tetsuo Hashiba, Masahiro Nonaka, Akio Asai, Koji Tsuta","doi":"10.5414/NP301641","DOIUrl":"10.5414/NP301641","url":null,"abstract":"<p><p>The \"Azzopardi phenomenon\" refers to the deposition of deeply basophilic, smudged material on the stromal blood vessels of highly cellular malignant tumors, and the material is considered to be derived from the nuclear chromatin liberated from necrotizing tumor cells. This phenomenon was observed in a case of high-grade astrocytoma with a primitive neuroectodermal tumor (PNET)-like component that arose in the frontal lobe of a 44-year-old man. The deeply basophilic material was deposited from the media to the adventitia of small or medium-sized blood vessels, and vascular smooth muscle cells largely disappeared. Endothelial cells were relatively preserved. The material was positive for the Feulgen reaction and immunoreactive for histone H3. The Azzopardi phenomenon is frequently seen in small cell lung carcinoma or retinoblastoma, but rare in tumors arising in the CNS. The present case is the first case of an astrocytic tumor that showed this phenomenon. This is also the first example in which histone protein was demonstrated to be co-deposited in the vascular walls in the Azzopardi phenomenon.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":"49-55"},"PeriodicalIF":0.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147582446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jeff Henderson, Adam McGlinchey, Bríd Murphy, Aoife Canney, Matthew Campbell, Michael Farrell
{"title":"Evidence of blood-brain barrier disruption in pathologic stage IV chronic traumatic encephalopathy without dementia.","authors":"Jeff Henderson, Adam McGlinchey, Bríd Murphy, Aoife Canney, Matthew Campbell, Michael Farrell","doi":"10.5414/NP301733","DOIUrl":"10.5414/NP301733","url":null,"abstract":"<p><p>Repetitive head injury in athletes has been increasingly linked to the development of chronic traumatic encephalopathy (CTE), a progressive neurodegenerative disorder. However, its underlying pathobiology remains poorly understood, and definitive diagnosis requires post-mortem examination due to the absence of established in-life biomarkers. Here, we report the neuropathological findings in a retired elite rugby union player with a prolonged history of repetitive head impacts and progressive behavioral changes in the decade preceding his death at the age of 60. The clinical course was characterized by gradually progressive behavioral and affective disturbance in the absence of overt cognitive impairment. Neuropathological findings were consistent with stage IV CTE, with phosphorylated tau (p-Tau) deposition involving neocortical, hippocampal, and midbrain regions, and exhibiting a characteristic distribution in the sulcal depths and perivascular zones. No β-amyloid, α-synuclein, or TDP-43 pathology was identified, suggesting the absence of coexistent neurodegenerative tauopathies. Analysis of blood-brain barrier (BBB) integrity demonstrated reduced claudin-5 immunoreactivity and diffuse immunoglobulin G extravasation in the sulcal depths, overlapping with dense p-Tau deposition, suggestive of BBB dysfunction. To our knowledge, this is the first description of BBB alterations in a case of CTE without dementia or evidence of a coexisting neurodegenerative disease. While based on a single case, warranting cautious interpretation, these findings add to accumulating evidence suggesting that BBB alteration may represent a hallmark feature of CTE.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":"66-75"},"PeriodicalIF":0.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147700794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ciara O'Donoghue, Beibhinn Wilkins, Alan Beausang, Jane Cryan, Michael Farrell, Jennifer Garry, Ciara Heeney, Josephine Heffernan, Rachel Howley, Niamh Kernan, Seamus Looby, Arooj Fatima, Alan Power, Ashling Spillane, Andrea Walsh, Francesca M Brett
{"title":"Retrospective neuropathologic analysis of adult spinal tumors in a single neuroscience center 2018 - 2023.","authors":"Ciara O'Donoghue, Beibhinn Wilkins, Alan Beausang, Jane Cryan, Michael Farrell, Jennifer Garry, Ciara Heeney, Josephine Heffernan, Rachel Howley, Niamh Kernan, Seamus Looby, Arooj Fatima, Alan Power, Ashling Spillane, Andrea Walsh, Francesca M Brett","doi":"10.5414/NP301722","DOIUrl":"10.5414/NP301722","url":null,"abstract":"<p><p>Spinal tumors are classified as extradural or intradural. The latter are further divided into intradural/extramedullary and intradural/intramedullary. The location, coupled with radiological assessment, intraoperative findings, size of biopsy, histological features, and molecular analysis serve to aid accurate diagnosis. We compiled a neuropathologic database of all adult (over 18 years) brain and spinal cord tumors diagnosed at the National Neuroscience Centre in Beaumont Hospital from 2018 to 2023. In this retrospective audit we identified 3,987 tumors, of which 90% (3,596) were intracranial and 10% (391) were spinal. The majority of the spinal tumors were intradural (n = 198) with extradural (n = 122) and intramedullary (n = 71) being much less common. In this review we outline the commonest tumors encountered, by location and age group, unusual tumors that may come to light, and difficulties that may arise, specifically with sampling.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":"42-48"},"PeriodicalIF":0.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147582150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}